Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by VanAsh01on Jul 21, 2017 11:34am

76 Views

Post# 26495033

RE:Post financing this is a new co. with the same great tech...

Give me a break. There are 2 businesses here and one is a public company where Jason Flowerchild has no experience. Your IR analysis is BS and we have already been diluted unnecessarily because of his lack of market experience. If we had the proper market making in place we would be financing at or above the previous one. If you think otherwise you are a fool.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"